Use the Search Fields to Find Information
Page 143 of 377
Long-term use of cannabis-based medicines in two children with Tourette syndrome: a case report
ABSTRACT Introduction: Cannabis-based medicine (CBM) is recommended for the treatment of tics in otherwise treatment-resistant adult patients with Tourette syndrome (TS). However, evidence in children with
February 8, 2026
Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy
Abstract Objective We report our findings regarding effectiveness, safety, and tolerability of cannabidiol (CBD)-enriched medical cannabis as add-on therapy in children with drug-resistant epileptic encephalopathies
February 8, 2024
Long-term safety of medical cannabis in Parkinson’s disease: A retrospective case-control study
Please use this link to access this publication. Abstract Background: Whole-plant medical cannabis (MC) products are widely used for controlling symptoms associated with Parkinson’s disease (PD).
September 5, 2024
Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy
Please use this link to access this publication. Abstract Objective To evaluate the safety, efficacy, and tolerability of highly purified cannabidiol (CBD) for the treatment
April 19, 2024
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long-term open-label extension trial
Summary Objective Lennox–Gastaut syndrome (LGS) is an epileptic encephalopathy that is often treatment resistant. Efficacy and safety of add-on cannabidiol (CBD) to treat seizures associated
April 23, 2024
Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety
Abstract Background and Objective This systematic review evaluated the effectiveness, tolerability and safety of cannabis-based medicines (CbMs) for chronic non-cancer pain (CNCP) in long-term observational
March 13, 2024
Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction
Please use this link to access this publication. Abstract Introduction: Human studies about the impact of cannabis use on both healthy kidneys as well as kidney
February 28, 2024
Long-term effects of prenatal cannabis exposure: Pathways to adolescent and adult outcomes
Please use this link to access this publication. Abstract With the increased prevalence, potency, and acceptability of cannabis use during pregnancy, it is important to understand the developmental
February 29, 2024
Long-term effects of maternal cannabis vapor exposure on emotional reactivity, social behavior, and behavioral flexibility in offspring
Please use this link to access this publication. Abstract The use of cannabis during pregnancy is a growing public health concern. As more countries implement
July 3, 2024
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients
Please use this link to access this publication. Abstract Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray was approved as add-on therapy for spasticity in patients with multiple
September 4, 2024
Page 143 of 377